GLP-1 drugs like Ozempic and Wegovy have revolutionized the management of diabetes and obesity. Millions of Americans are experimenting with them. Celebrities like Oprah are sharing their experiences. Duke Sanford School of Public Policy faculty member Jonathan Zhang is an economist who works on health policy, health economics and public finance. His research shows that GLP-1 drugs live up to their promise in everyday medical care. But the study also finds that, at least in the short run, they do not reduce overall health care spending.

Duke Sanford School of Public Policy Professor Anirudh Krishna has been studying a seemingly simple question: why do people in certain countries just seem better at some things than others? Think of the large number of world-class runners from Jamaica like Usain Bolt and Shelly-Ann Fraser-Pryce, or the long list of top female golfers from South Korea. Why are people in tiny Estonia keep hatching software companies worth billions? Krishna's research shows that these examples are due in large part to structures that are specifically designed to support the rise of talent. By giving a fair chance to everyone these "ladders of opportunity" both produce champions and serve as avenues of upward mobility, supporting community development. Krishna's TED Talk, The 7 Pillars of Unlocking Potential, has garnered half a million views. His latest book is The Broken Ladder: The Paradox and Potential of India's One-Billion.

As 21st Chairman of the Joint Chiefs of Staff General CQ Brown, Jr. advised the President, the Secretary of Defense, and the National Security Council. He now serves as an executive in residence at Duke with appointments in the Sanford School of Public Policy and the Pratt School of Engineering. Over his career, General Brown has held many different roles. As a pilot with the U.S. Air Force, he has logged more than 3,100 flying hours. He also served as the first African American chief of a U.S. military service, the Air Force, and was unanimously confirmed for that role by the Senate in 2020.